Educational article
Fluoroquinolones
Fluoroquinolones act on DNA gyrase and topoisomerase IV, enzymes involved in bacterial DNA processes. Ciprofloxacin, levofloxacin and other members have different spectra. Laboratory activity cannot be equated directly…
Overview
Fluoroquinolones act on DNA gyrase and topoisomerase IV, enzymes involved in bacterial DNA processes. Ciprofloxacin, levofloxacin and other members have different spectra. Laboratory activity cannot be equated directly with safety or preferred prescribing.
Biology and practical meaning
Resistance can involve target changes, enhanced efflux and plasmid-mediated determinants. A low-level mechanism may facilitate selection of additional changes. Interpretation depends on the organism and agent; a qnr gene and an R category are not synonymous.
Spectrum, exposure and AST
Spectrum describes the range of organisms an agent can act against; activity against a particular isolate is assessed separately. Access to the target, target changes, enzymes and efflux can alter activity. Agents in the same class are not completely interchangeable.
Pharmacokinetics describes distribution and elimination; pharmacodynamics links exposure to effect. Blood concentrations and exposure at the infection site can differ. A lower MIC number for a different antibiotic therefore does not establish superior clinical activity.
S, I and R are interpreted using a current standard for the organism–agent pair. Under EUCAST, I means susceptible with increased exposure. It does not mean resistant and does not independently specify a treatment regimen. Decisions also depend on the site, patient, contraindications, interactions and current guidance. This article explains mechanisms and terminology. The 2025 AWaRe classification concerns use policy, while the 2022 AWaRe book has subsequent updates; neither replaces an individual AST result.
Teaching example: from finding to conclusion
Teaching example: qnr is detected but the MIC remains below the R breakpoint. Genetic and clinical findings are not automatically contradictory. The mechanism’s contribution can be low-level and combined with additional changes.
Surveillance may record the determinant, whereas clinical categorisation follows the current standard. R cannot be assigned solely from a gene name without an accepted rule. Resistance-evolution studies retain the original MIC and genetic evidence separately.
Sources
Read next
Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.